In vitro and in vivo modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α1-antitrypsin
暂无分享,去创建一个
M. Henry | P. Meleady | N. McElvaney | Orla Coleman | D. Bergin | E. Reeves | M. Murphy | T. McEnery | Vipatsorn Shutchaidat | P. Hawkins | C. Gabillard-Lefort | Bader Alfawaz | M. Henry
[1] F. Blasi,et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. , 2021, The Lancet. Respiratory medicine.
[2] N. McElvaney,et al. Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis , 2020, Frontiers in Immunology.
[3] N. McElvaney,et al. Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency. , 2020, Chronic obstructive pulmonary diseases.
[4] M. Henry,et al. α1 Antitrypsin therapy modulates the neutrophil membrane proteome and secretome , 2020, European Respiratory Journal.
[5] R. Stockley,et al. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial , 2019, American journal of respiratory and critical care medicine.
[6] M. Henry,et al. Glycosylation Repurposes Alpha‐1 Antitrypsin for Resolution of Community‐acquired Pneumonia , 2017, American journal of respiratory and critical care medicine.
[7] J. Mecsas,et al. Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance , 2017, Front. Cell. Infect. Microbiol..
[8] N. McElvaney,et al. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. , 2016, Annals of the American Thoracic Society.
[9] M. Wormald,et al. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling , 2015, The Journal of Immunology.
[10] Berend C Stoel,et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.
[11] N. McElvaney,et al. Alpha-1 Antitrypsin Augmentation Therapy Corrects Accelerated Neutrophil Apoptosis in Deficient Individuals , 2014, The Journal of Immunology.
[12] M. Henry,et al. A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. , 2014, Blood.
[13] N. McElvaney,et al. The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity , 2014, Science Translational Medicine.
[14] P. Kirkham,et al. Oxidative stress in COPD. , 2013, Chest.
[15] R. Stockley,et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.
[16] N. McElvaney,et al. The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell , 2011, Archivum Immunologiae et Therapiae Experimentalis.
[17] M. Henry,et al. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. , 2010, The Journal of clinical investigation.
[18] Lin Ying Liu,et al. Human Airway Eosinophils Respond to Chemoattractants with Greater Eosinophil-Derived Neurotoxin Release, Adherence to Fibronectin, and Activation of the Ras–ERK Pathway When Compared with Blood Eosinophils , 2010, The Journal of Immunology.
[19] N. McElvaney,et al. Evidence for Unfolded Protein Response Activation in Monocytes from Individuals with α-1 Antitrypsin Deficiency , 2010, The Journal of Immunology.
[20] P. King. The pathophysiology of bronchiectasis , 2009, International journal of chronic obstructive pulmonary disease.
[21] N. McElvaney,et al. Proteases and antiproteases in chronic neutrophilic lung disease – relevance to drug discovery , 2009, British journal of pharmacology.
[22] I. Petrache,et al. Mechanism of α‐1 antitrypsin endocytosis by lung endothelium , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] J. Fahy,et al. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. , 2009, Proceedings of the American Thoracic Society.
[24] Naoko Nakamura,et al. A Feeder‐Free and Efficient Production of Functional Neutrophils from Human Embryonic Stem Cells , 2009, Stem cells.
[25] Hongwei Yao,et al. Future therapeutic treatment of COPD: Struggle between oxidants and cytokines , 2007, International journal of chronic obstructive pulmonary disease.
[26] J. Roca,et al. Oxidative stress and airway inflammation in severe exacerbations of COPD , 2005, Thorax.
[27] A. Churg,et al. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. , 2003, American journal of respiratory and critical care medicine.
[28] P. Vignais. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism , 2002, Cellular and Molecular Life Sciences CMLS.
[29] Giorgio Gabella,et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.
[30] J. Moss,et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. , 2000, The Journal of biological chemistry.
[31] Farshid N. Rouhani,et al. Lung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency , 2000, Chest.
[32] A. Mócsai,et al. Kinase Pathways in Chemoattractant-Induced Degranulation of Neutrophils: The Role of p38 Mitogen-Activated Protein Kinase Activated by Src Family Kinases1 , 2000, The Journal of Immunology.
[33] T. Yoneda,et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. , 1997, Chest.
[34] J. Potempa,et al. Biosynthesis of α1-Proteinase Inhibitor by Human Lung-derived Epithelial Cells* , 1997, The Journal of Biological Chemistry.
[35] D. Lomas,et al. α1-antitrypsin deficiency , 2005, The Lancet.
[36] R. Snyderman,et al. Functional high efficiency expression of cloned leucocyte chemoattractant receptor cDNAs , 1992, FEBS letters.
[37] R. Crystal,et al. Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes , 1991 .
[38] R. Crystal,et al. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. , 1991, The Journal of clinical investigation.
[39] V. Ferrans,et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. , 1991, Blood.
[40] J. Pierce,et al. The alpha 1-antitrypsin gene and emphysema. , 1989, The American journal of physiology.
[41] L. Koenderman,et al. Eosinophils do respond to fMLP. , 1987, Blood.
[42] R. Crystal,et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. , 1987, The New England journal of medicine.
[43] R. Crystal,et al. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. , 1981, The Journal of clinical investigation.
[44] M. Sanak,et al. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). , 2017, The Lancet. Respiratory medicine.
[45] Michael J Morgan,et al. Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.
[46] N. Porchet,et al. Evaluation of a new Sebia isoelectrofocusing kit for α1-antitrypsin phenotyping with the Hydrasys® System , 2008, Clinical chemistry and laboratory medicine.
[47] A. Segal,et al. How neutrophils kill microbes. , 2005, Annual review of immunology.
[48] J. El-Benna. The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47 Phosphorylation in Human Neutrophils , 2000 .
[49] O. Götze,et al. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. , 1999, Blood.
[50] D. Blake,et al. Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. , 1992, FEBS letters.
[51] A. Solomon,et al. Alpha 1-antitrypsin deficiency associated with panniculitis. , 1988, Journal of the American Academy of Dermatology.